Avadel Pharmaceuticals PLC (AVDL)
17.30
-0.03
(-0.17%)
USD |
NASDAQ |
Apr 22, 16:00
17.30
0.00 (0.00%)
After-Hours: 20:00
Avadel Pharmaceuticals Cash from Financing (TTM): 135.34M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 135.34M |
| September 30, 2023 | 163.07M |
| June 30, 2023 | 143.32M |
| March 31, 2023 | 46.98M |
| December 31, 2022 | 14.54M |
| September 30, 2022 | 7.921M |
| June 30, 2022 | -2.68M |
| March 31, 2022 | 2.123M |
| December 31, 2021 | 0.263M |
| September 30, 2021 | 0.446M |
| June 30, 2021 | 0.316M |
| March 31, 2021 | 117.62M |
| December 31, 2020 | 179.68M |
| September 30, 2020 | 179.46M |
| June 30, 2020 | 179.43M |
| March 31, 2020 | 62.09M |
| December 31, 2019 | -0.027M |
| September 30, 2019 | -0.062M |
| June 30, 2019 | -0.446M |
| March 31, 2019 | -10.16M |
| December 31, 2018 | 112.66M |
| September 30, 2018 | 106.71M |
| June 30, 2018 | 103.20M |
| March 31, 2018 | 100.00M |
| December 31, 2017 | -23.32M |
| Date | Value |
|---|---|
| September 30, 2017 | -17.23M |
| June 30, 2017 | -13.92M |
| March 31, 2017 | -1.381M |
| December 31, 2016 | -7.954M |
| September 30, 2016 | -15.51M |
| June 30, 2016 | -20.27M |
| March 31, 2016 | -30.65M |
| December 31, 2015 | -23.75M |
| September 30, 2015 | -3.323M |
| June 30, 2015 | 4.204M |
| March 31, 2015 | 15.84M |
| December 31, 2014 | 96.00M |
| September 30, 2014 | 86.96M |
| June 30, 2014 | 84.62M |
| March 31, 2014 | 84.03M |
| December 31, 2013 | 18.27M |
| September 30, 2013 | 14.24M |
| June 30, 2013 | 15.12M |
| March 31, 2013 | 20.54M |
| December 31, 2012 | 6.955M |
| September 30, 2012 | 7.236M |
| June 30, 2012 | 7.075M |
| March 31, 2012 | 8.724M |
| December 31, 2011 | 6.145M |
| September 30, 2011 | 6.189M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-2.68M
Minimum
Jun 2022
179.68M
Maximum
Dec 2020
64.70M
Average
14.54M
Median
Dec 2022
Cash from Financing (TTM) Benchmarks
| Trinity Biotech PLC | -15.68M |
| Medtronic PLC | -6.981B |
| Biophytis SA | 7.617M |
| Jazz Pharmaceuticals PLC | -305.25M |
| DBV Technologies SA | 6.767M |